Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study

• Asıl Yazarlar: Brian L.P. Dizon (Yazar), Christopher Redmond (Yazar), Emily C. Gotschlich (Yazar), Sangeeta Sule (Yazar), Tova Ronis (Yazar), Kathleen M. Vazzana (Yazar), Matthew A. Sherman (Yazar), Rachael Connor (Yazar), Abigail Bosk (Yazar), Niti Dham (Yazar), Ashraf S. Harahsheh (Yazar), Elizabeth Wells (Yazar), Roberta DeBiasi (Yazar), Hemalatha Srinivasalu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2023-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background and objective Evidence for the treatment of multisystem inflammatory syndrome in children (MIS-C) is lacking. Anakinra, which targets IL-1-mediated inflammation, is reserved for refractory cases of MIS-C; however, its use in the treatment of MIS-C is not clearly established. Pati...